» Articles » PMID: 33212306

Less Than Subtotal Parathyroidectomy in Multiple Endocrine Neoplasia Type 1: A Case Report and Review of the Literature

Overview
Specialty General Surgery
Date 2020 Nov 19
PMID 33212306
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Multiple endocrine neoplasia type 1 (MEN1) is a rare syndrome with common presenting signs and symptoms secondary to primary hyperparathyroidism (PHPT), which is managed surgically. Traditionally, either subtotal parathyroidectomy (SPTX) or total parathyroidectomy with autologous transplantation (TPTX) is the approach of choice. However, recent studies showed comparable persistence and recurrence rate in a subset of MEN1 patients (two or more concordant preoperative imaging results) who underwent less than subtotal parathyroidectomy (LSPTX).

Presentation Of Case: We report a case of patient with PHPT and delayed diagnosis of MEN1, who underwent LSPTX without intraoperative parathyroid hormone (IOPTH) measurement. The approach was chosen based on the preoperative imaging studies. Unfortunately, the PHPT persisted and the patient was reoperated. To further elucidate the issue, a systematic search of the literature was conducted on Cochrane library, PubMed, and Scopus; articles relevant to the case were reviewed. Results are conflicting results with most of the studies showed LSPTX is inferior compared to the other two approaches.

Discussion: Therefore, given the current body of evidence, we consider that subtotal or total parathyroidectomy is still the preferred surgical approach for the treatment of PHPT in MEN1.

Conclusion: Further studies are still needed to see whether LSPTX is comparable to SPTX or TPTX in regards to persistent and recurrent hyperparathyroidism if the conditions are met.

Citing Articles

Neuroendocrine tumors in a patient with multiple endocrine neoplasia type 1 syndrome: A case report and review of the literature.

Deng J, Liao X, Cao H Medicine (Baltimore). 2023; 102(29):e34350.

PMID: 37478229 PMC: 10662830. DOI: 10.1097/MD.0000000000034350.


[Less-than-subtotal parathyroidectomy in MEN1-ralated primary hyperparathyroidism: a case report].

Ning J, Xie D, Li J, Miao G Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022; 36(3):222-225.

PMID: 35193346 PMC: 10128291. DOI: 10.13201/j.issn.2096-7993.2022.03.013.

References
1.
Nilubol N, Weisbrod A, Weinstein L, Simonds W, Jensen R, Phan G . Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy. World J Surg. 2013; 37(8):1966-72. PMC: 8369518. DOI: 10.1007/s00268-013-2054-1. View

2.
Komminoth P, Heitz P, Kloppel G . Pathology of MEN-1: morphology, clinicopathologic correlations and tumour development. J Intern Med. 1998; 243(6):455-64. DOI: 10.1046/j.1365-2796.1998.00274.x. View

3.
Keutgen X, Nilubol N, Agarwal S, Welch J, Cochran C, Marx S . Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism. Ann Surg Oncol. 2016; 23(Suppl 5):701-707. PMC: 6415766. DOI: 10.1245/s10434-016-5467-x. View

4.
Montenegro F, Brescia M, Lourenco Jr D, Arap S, dAlessandro A, de Britto E Silva Filho G . Could the Less-Than Subtotal Parathyroidectomy Be an Option for Treating Young Patients With Multiple Endocrine Neoplasia Type 1-Related Hyperparathyroidism?. Front Endocrinol (Lausanne). 2019; 10:123. PMC: 6417394. DOI: 10.3389/fendo.2019.00123. View

5.
Kluijfhout W, Beninato T, Drake F, Vriens M, Gosnell J, Shen W . Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1. World J Surg. 2016; 40(12):2964-2969. PMC: 5104782. DOI: 10.1007/s00268-016-3624-9. View